戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 enamide (TAF)/emtricitabine (FTC; <36 months prescreening).
2 requiring treatment with and without genetic prescreening.
3 ntify the net benefits from applying species prescreening.
4                         Notwithstanding this prescreening, 84 de novo SNVs affecting the coding regio
5              Of 213 HCWs who participated in prescreening, 95 attended in-person visits, resulting in
6                               Development of prescreening algorithms using routinely available digiti
7 e use of in vitro efficacy results alone for prescreening and improves in vitro-in vivo translation b
8                                Using gSOS in prescreening and limiting further assessment to those wi
9 re needed to assess the potential benefit of prescreening and prophylactically treating heterotaxy pa
10 ition of OCTA to PUT allows for quantitative prescreening and real time monitoring of treatment respo
11 orectal dysplasia, detecting adenocarcinoma, prescreening, and prioritizing the reviewing of suspicio
12 ds promise for improved detection and future prescreening applications.
13                               An integrative prescreening approach is developed for the analysis of m
14 -PCR assay for </=40% of the bDNA test cost, prescreening bDNA requests by RT-PCR may be the most cos
15  12 months, a significant improvement over a prescreening cohort of newborns with CF from 20 years be
16                           The possibility of prescreening cork stoppers for TCA contamination would b
17 suggests a need to reevaluate the process of prescreening dengue vaccine candidates to better predict
18 be an in vitro characterization pipeline for prescreening device designs to identify promising candid
19 f human PBGS were identified using in silico prescreening (docking) of approximately 111,000 structur
20 ementary in vitro model to animal models for prescreening drug candidates for the treatment of neurol
21 mong eligible patients, the effectiveness of prescreening education, attitudes toward the screening p
22                  From 1965 to June 1974 (the prescreening era), the age- and sex-adjusted incidence o
23                                           A "prescreening" event occurs by activation of the top N pe
24 study is a large-scale validation of a model prescreening FGFR3 mutations for MIBC and mUC patients.
25 f MSI and immunohistochemistry for molecular prescreening followed by gene sequencing and deletion an
26 f 4298 CDP scaffolds and performed in silico prescreening for CDP binders to targets of interest.
27 ple testing were used, both with and without prescreening for marginal genetic associations.
28 of unique visitors who completed the trial's prescreening form and (2) engagement defined as (a) mean
29 the number of tests performed is achieved by prescreening gene combinations with a goodness-of-fit ch
30          We developed an efficient method of prescreening GGAA and ATA microsatellite clones for Alu
31                              Without genetic prescreening, guideline recommendations achieved a sensi
32 mulation shows that the proposed integrative prescreening has better performance than alternatives, p
33 e system, defined as Healthcare From the Eye prescreening, has the potential to improve access, affor
34                        The implementation of prescreening in a coordinated care system, defined as He
35                      The potential for using prescreening in Drosophila to inform combinatorial thera
36  molecular diagnosis after extensive genetic prescreening, including microarray-based CNV studies and
37 levated ApoB could potentially be reduced by prescreening individuals with PRSs.
38 dence validating our hypothesis will support prescreening individuals with SCD for preleukemic progen
39 that AF-M-based models could be valuable for prescreening interactions but experimentally measuring i
40                      This article focuses on prescreening, its use with retinal images analyzed by ar
41 ction of screening but has never returned to prescreening levels.
42                        It might be useful as prescreening marker to avoid unnecessary endoscopies.
43 clinical risk calculator is a cost-effective prescreening method to identify CS-like patients for PTE
44                                      The new prescreening methodology proves to be a powerful tool fo
45 tatus is comparable to that of other popular prescreening methods.
46 rogram first uses automated outreach (mailed prescreening notification postcards and fecal immunochem
47 od B cells of infected individuals, based on prescreening of Ab activity in the serum.
48 le-ion trap-Orbitrap platform, which enables prescreening of aminoxyTMT labeled N-glycan precursor io
49 f photo-CIDNP SNE, which will enable virtual prescreening of compound libraries.
50                                              Prescreening of CP may be necessary for selecting donors
51 ila may be used as simple models for in vivo prescreening of drug candidates.
52 plex labeling) could be used efficiently for prescreening of GGAA clones.
53 onfirmation of analyte identity is required, prescreening of large numbers of samples or in situ moni
54 ages during routine eye examinations enables prescreening of large populations for chronic disease.
55                                 Experimental prescreening of MOFs was performed based on changes in t
56 ites will be rare, underscoring the need for prescreening of patients through whole-genome sequencing
57  The voltammetric procedure was evaluated by prescreening of SCs in 12 confiscated street samples tha
58 n silico cross-panning enabled computational prescreening of specificity, and molecular dynamics simu
59                     These data indicate that prescreening of subjects may be of benefit in future tri
60  consequently allowing for the computational prescreening of substituent combinations to best match t
61          Voltammetry provides a tool for the prescreening of synthetic cannabinoid derivatives in sei
62 irus therapy for prostate tumors may require prescreening of tumors for their level of susceptibility
63 h subsequent chemometric analysis toward the prescreening of virus-infected samples.
64 itive biosignature, and magnetic forces as a prescreening option.
65       Of the 4855 patients who had undergone prescreening or screening, 270 were assigned to receive
66 e results challenge the established fragment prescreening paradigm since the standard industrial filt
67 mediated liver transduction, suggesting that prescreening patient sera in this manner accurately pred
68         These new data raise the question of prescreening patients not only for the humoral response,
69 e of breast cancer patients diagnosed in the prescreening period (1975-1981), adjusted for the curren
70 ced tumors increased in the screening versus prescreening periods (incidence rate ratio, 1.49 [95% CI
71                        In silico methods for prescreening potential NR binders with predictive bindin
72 inal exploitation round, aided by solubility prescreening, predicted twelve materials exhibiting both
73 city in preschool children with 53% (96/180) prescreening probability and 31% (55/177) developmental
74                                          The prescreening process informed conversion pathway selecti
75                      An effective method for prescreening prodrugs was found to be the acute murine l
76                     The proposed integrative prescreening provides an effective way to reduce the dim
77 nfants were aged 4 to 10 months and passed a prescreening questionnaire.
78 ostic accuracy of screening tools (including prescreening questionnaires and spirometry); whether scr
79                   Of 248 patients with FGFR2 prescreening results, 27 (11%) had FGFR2(mut) endometria
80 thod validation studies; (2) lot control and prescreening sample collection materials are important q
81 approach improved analytical accuracy due to prescreening selectivity with fluorescence, leading to m
82  perks significantly improved engagement and prescreening sign-up rates, demonstrating that they may
83 ccess to perks would increase engagement and prescreening sign-ups compared with a standard contribut
84 nce comparisons, should be quite useful as a prescreening step prior to functional analysis with corr
85                 Logistical issues related to prescreening strategies and trial allocation, in additio
86 ping a minimally invasive and cost-effective prescreening strategy for colon cancer is critical becau
87           This approach provides a potential prescreening strategy for risk stratification before col
88 may potentially herald a minimally intrusive prescreening test that could be integral to the success
89                                          The prescreening tests (tier alpha and beta) show the averag
90   We expect that this tool could be used for prescreening to accelerate or even automate the use of D
91 cipants, and for long-term follow-up; use of prescreening to facilitate rapid recruitment of particip
92 rmance of the immunochips was optimized as a prescreening tool for L. pneumophila.
93  a large quantity of bacterial cells or as a prescreening tool for microbial discrimination.
94 uptake as a collective may serve as a useful prescreening tool for the advancement of LNPs in vivo.
95 TMP constitutes a promising, novel molecular prescreening tool in mCRC to identify protein expression
96      NMR spectroscopy can be used as a rapid prescreening tool to discriminate Arabica and Robusta co
97  clinical conditions, and it will serve as a prescreening tool to maximize the number of genetically
98                       ADS may be useful as a prescreening tool to promote proactive cardiac evaluatio
99 al of computational approaches to serve as a prescreening tool, helping prioritize cases for IHC stai
100                Such markers could be used as prescreening tools to reduce the cost of prevention tria
101           Considering their potential use as prescreening tools, these models could provide in vivo t
102 munohistochemistry may be a rapid method for prescreening tumors for mutations in the MMR genes.
103 t be cost-effective for all trauma patients, prescreening using risk assessment profile yielded a coh
104                                              Prescreening, variable selection algorithms, and publica
105 tudy evaluated a two-step workflow combining prescreening via smell-function testing with confirmator
106 gies, including strategies with SCORE or QUS prescreening, were also cost-effective, and in general t
107  to measurements without fluorescence guided prescreening, where only 9 +/- 3% of MPs were identified
108       A computationally affordable remedy is prescreening, which fits marginal models, can be conduct
109  and 24% of ApoB testing could be reduced by prescreening with a PRS while maintaining a low false-ne
110                         We hypothesized that prescreening with a risk assessment profile followed by
111                                              Prescreening with BNP +/- cTnT followed by targeted phen
112 ce than alternatives, particularly including prescreening with individual datasets, an intensity appr
113                                              Prescreening with primers designed for ATA microsatellit
114 nd affordable amounts of the detergents, and prescreening with SDS-gel electrophoresis ensured effici

 
Page Top